Trials / Withdrawn
WithdrawnNCT05184231
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the protocol is to achieve an in-depth understanding of the current satisfaction status of somatostatin analogue (SSA) treatment for acromegaly through patient and physician surveys.
Conditions
Timeline
- Start date
- 2023-02-13
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
- First posted
- 2022-01-11
- Last updated
- 2023-03-17
Source: ClinicalTrials.gov record NCT05184231. Inclusion in this directory is not an endorsement.